New osteoporosis drug safety checked in indian women

NCT ID NCT06079476

First seen Nov 03, 2025 · Last updated May 09, 2026 · Updated 25 times

Summary

This study tested the safety of a drug called romosozumab (EVENITY) in 100 postmenopausal women in India who have osteoporosis and a high risk of breaking a bone. The main goal was to see what side effects occurred. The drug is already approved and aims to strengthen bones, but this study focused on how well it was tolerated in this specific group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL OSTEOPOROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Apollo Hospital

    New Delhi, National Capital Territory of Delhi, 110076, India

  • Christain Medical College

    Vellore, Tamil Nadu, 632004, India

  • King Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College

    Mumbai, Maharashtra, 400012, India

  • King Georges Medical University

    Lucknow, Uttar Pradesh, 226 003, India

  • MGM Healthcare

    Chennai, Tamil Nadu, 600 029, India

  • MS Ramaiah Medical College and Hospitals

    Bangalore, Karnataka, 560054, India

  • Post Graduate Institute of Medical Education and Research

    Chandigarh, Punjab, 160 012, India

  • Sancheti Institute for Orthopedics and rehabilitation

    Pune, Maharashtra, 411005, India

  • Sir Ganga Ram Hospital

    New Delhi, National Capital Territory of Delhi, 110060, India

  • Stavya Spine Hospital and Research Institute SSHRI

    Ahmedabad, Gujarat, 380 007, India

Conditions

Explore the condition pages connected to this study.